Stromal Cell–Derived Factor-1 Plasmid Treatment for Patients With Peripheral Artery Disease (STOP-PAD) Trial: Six-Month Results:

Tarek A. Hammad,John H. Rundback,Matthew C. Bunte,Leslie W. Miller,Parag D. Patel,Saihari Sadanandan,Michael L. Fitzgerald,Joseph M. Pastore,Vikram S. Kashyap,Timothy D. Henry,Mehdi H. Shishehbor

Stromal Cell–Derived Factor-1 Plasmid Treatment for Patients With Peripheral Artery Disease (STOP-PAD) Trial: Six-Month Results:

2020

Tarek A. Hammad
John H. Rundback
Matthew C. Bunte
Leslie W. Miller
Parag D. Patel
Saihari Sadanandan
Michael L. Fitzgerald
Joseph M. Pastore
Vikram S. Kashyap
Timothy D. Henry
Mehdi H. Shishehbor

Purpose: To present the 6-month results of the Stromal Cell–Derived Factor-1 Plasmid Treatment for Patients with Peripheral Artery Disease (STOP-PAD) trial. The trial was an attempt to alter the co...

Keywords:

Revascularization
Wound healing
Randomized controlled trial
Plasmid
Internal medicine
Stromal cell-derived factor 1
Stromal cell
Gastroenterology
Amputation
Disease
Medicine
Cardiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations